Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29 nov. 2022 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
Qualigen Therapeutics, Inc. Announces 1-for-10 Reverse Stock Split
22 nov. 2022 09h00 HE
|
Qualigen Therapeutics, Inc.
Action to comply with continued listing requirements for Nasdaq Capital Market CARLSBAD, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN Qualigen Therapeutics,...
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
15 août 2022 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
24 mars 2022 16h24 HE
|
Nemaura Medical, Inc
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and...
Cocrystal Pharma to Participate in Upcoming Investment Conferences
03 mars 2022 08h00 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., March 03, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that management will participate in two upcoming investment conferences as follows: Q1 Investor...
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
03 févr. 2022 08h30 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at...
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
23 nov. 2021 16h15 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new...
Nemaura Medical to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
01 juin 2021 08h05 HE
|
Nemaura Medical, Inc
Loughborough, England, June 01, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...